Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial - Université de Rennes Access content directly
Journal Articles Blood Year : 2015

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Marie C. Bene
  • Function : Author
Ariane C. Mineur
  • Function : Author
Thibaut Leguay
  • Function : Author
Romain Guièze
  • Function : Author
Mario Ojeda
  • Function : Author
Anne Banos
  • Function : Author
Hacène Zerazhi
  • Function : Author
  • PersonId : 897383
Hichri Yosr
  • Function : Author
Jean-Yves Cahn
  • Function : Author

Abstract

no abstract
No file

Dates and versions

hal-01295674 , version 1 (31-03-2016)

Identifiers

Cite

Arnaud Pigneux, Christian Récher, Marie C. Bene, Julien Asselineau, Ariane C. Mineur, et al.. Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial. Blood, 2015, 126 (23), ⟨10.1182/blood.v126.23.3736.3736⟩. ⟨hal-01295674⟩
1299 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More